Showing 271-280 of 790 results for "".
Bellafill Fills a Niche; Soolantra Targets Rosacea
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-bellafill-fills-a-niche-soolantra-targets-rosacea-/18995/In this edition of DermWireTV from the editors of Practical Dermatology® magazine, a look at the approval of Bellafill (Suneva) to treat acne scars and Soolantra (Ivermectin 1%, Galderma) to treat rosacea. Plus, Benzac (Galderma) is now available OTC to treat acne, and Opdivo (Bristol-Myers Squibb)Implications of the Overlap Between CSU and Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/implications-of-the-overlap-between-csu-and-atopic-dermatitis/50850/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, is joined by Northwestern University Feinberg School of Medicine Associate Professor Walter Liszewski, MD, to discuss the article “Co-existence of chronic spontaneous urticaria and atopic dermatitis: clinical and immunological perspecThe Safety of New Systemics
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/the-safety-of-new-systemics/33159/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, provides an overview of the safey of systemic therapies such as JAK inhibitors and other similar drugs, giving dermatologists a high-level look at what they need to help clinical decision-making.Why Assessing Vitiligo Activity is Critical for Limiting Spread
https://practicaldermatology.com/conferences/maui-derm-2024/why-assessing-vitiligo-activity-is-critical-for-limiting-spread/20248/Chief Medical Editor Neal Bhatia, MD talks with “Mr. Vitiligo Himself,” John E. Harris, MD, PhD about the importance of determining whether vitiligo patients are active or stable in order to “shut off” spreading as soon as possible.DermWire TV Extra: How ILDS Helps Dermatology Go Global
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-extra-how-ilds-helps-dermatology-go-global/26912/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Henry Lim, MD, president of the International League of Dermatology Societies (ILDS), to discuss international developments in research and therapeutics, how ILDS helps enhance dermatologists' interactions with the specialty worlManaging Office Politics
https://practicaldermatology.com/topics/practice-management/managing-office-politics/19101/Neal Bhatia, MD, Co-Chief Medical Editor of Practical Dermatology® magazine, shares pearls for successfully understanding and navigating the scope of office politics and relationships. DermTube's coverage of the AAD's 2014 Summer Meeting is not endorsed by or affiliated with the American Academy ofPrurigo Nodularis, Chronic Itch, and Lymphoma Risk
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/prurigo-nodularis-chronic-itch-and-lymphoma-risk/50965/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Lawrence Green, MD, FAAD, examine the link between prurigo nodularis, chronic pruritus, Type 2 inflammation, and lymphoma risk, with a focus on evaluating the underlying causes of persistent itch.Exploring Dupilumab's Impact on Growth in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/exploring-dupilumabs-impact-on-growth-in-pediatric-atopic-dermatitis/50962/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Michelle Tarbox, MD, FAAD, discuss emerging evidence and real-world experiences demonstrating how effective control of atopic dermatitis with dupilumab may support healthy growth and development in pediatric patieUnmet Needs in Atopic Dermatitis Management
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/unmet-needs-in-atopic-dermatitis-management/37145/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, says the most pressing unmet needs in atopic dermatitis management today involve the targets of therapyDeveloping Core Outcome Sets: The Importance of Common Standards for Clinical Studies of Specific Diseases and Conditions
https://practicaldermatology.com/topics/feature/developing-core-outcome-sets-importance-common-standards-clinical-studies-specific-diseases-and-conditions/26654/Developing Core Outcome Sets: The Importance of Common Standards for Clinical Studies of Specific Diseases and Conditions